Showing results (1471-1480 of 8,962) with videos related to
Sort By:
Pageof 897
Journal of Hepatology|February 1, 1987
The effect of prostaglandins, branched-chain amino acids and other drugs on the outcome of experimental acute porcine hepatic failureM H Alp, R HickmanJournal of Hepatology|June 20, 2022
EASL Clinical Practice Guidelines on the management of hepatic encephalopathyJournal of Hepatology|June 24, 2022
Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASHTim Hendrikx, Florentina Porsch, Máté G Kiss, et al.Journal of Hepatology|November 19, 2020
Predicting the risk of post-hepatectomy portal hypertension using a digital twin: A clinical proof of conceptNicolas Golse, Florian Joly, Prisca Combari, et al.Journal of Hepatology|November 19, 2020
Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinomaYu-Hua Huang, Chris Zhi-Yi Zhang, Qun-Sheng Huang, et al.Journal of Hepatology|November 16, 2020
IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expressionStephanie Stein, Lara Henze, Tobias Poch, et al.Journal of Hepatology|November 16, 2020
ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinomaMaria Arechederra, Sehrish K Bazai, Ahmed Abdouni, et al.Journal of Hepatology|May 31, 2021
Early liver transplantation for acute alcoholic hepatitis: We can't say noPhilippe MathurinJournal of Hepatology|February 23, 2020
Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12Juan P Arab, Daniel Cabrera, Tejasav S Sehrawat, et al.Journal of Hepatology|February 24, 2020
IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responsesJi Won Han, Pil Soo Sung, Seon-Hui Hong, et al.Pageof 897